Glenmark Life Sciences to expand geographical markets and CDMO business
Glenmark Life Sciences Limited, a leading developer and manufacturer of select high value, non-commoditized active pharmaceutical ingredients (API) in chronic therapeutic areas, is planning to expand geographical markets and to grow contract development and manufacturing organization (CDMO) business
Glenmark Life Sciences To Expand Geographical Mark | 27/07/2021 | By Darshana | 166
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy